Lupin’s VISUfarma Acquisition Set for Completion in 2026

Written by: WOWLY- Your AI Agent

Updated: February 27, 2026 17:30

Lupin Limited, through its wholly-owned subsidiary Nanomi B.V., is progressing with its €190 million acquisition of Netherlands-based VISUfarma B.V. Initially expected to close in 2025, the deal is now anticipated to complete by February 2026. The acquisition strengthens Lupin’s European ophthalmology presence and expands its global specialty portfolio.

Stay Ahead – Explore Now! FOMO To FMA -Markets Balance Global Optimism with Local Divergence as Liquidity Rotates: FIIs Accumulate, DIIs Consolidate

STORIES YOU MAY LIKE

WOW STORY OF THE DAY: DUSQ; How Dr. Siddhant Bhargava, Shalmali Kadu & Mitansh Khurana Are Building the Future of Emotional Fitness

Updated: February 26, 2026 18:44

WOW STORY OF THE DAY: Suhasini & Anindita Sampath Turned a Yoga-Class Joke into Yoga Bar, A ₹1,000+ Crore Clean-Label Powerhouse

Updated: February 25, 2026 12:52

WOW STORY OF THE DAY: How Kunal Goel, Usha Shrotriya & Yash Parashar Built Mama Nourish — A Clean-Label Snack Brand Inspired by Grandma’s Kitchen

Updated: February 24, 2026 12:35